Combined antiangiogenic and anti–PD-L1 therapy stimulates tumor immunity through HEV formation

Title
Combined antiangiogenic and anti–PD-L1 therapy stimulates tumor immunity through HEV formation
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 9, Issue 385, Pages eaak9679
Publisher
American Association for the Advancement of Science (AAAS)
Online
2017-04-13
DOI
10.1126/scitranslmed.aak9679

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search